- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02594540
Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation
January 11, 2017 updated by: Aline de Souza Pagnussat, Federal University of Health Science of Porto Alegre
Effects of the Mechanical Peripheral Stimulation for Parkinson's Disease Rehabilitation - A Randomized Clinical Trial
The purpose of this study is to evaluate safety and effectiveness of the peripheral mechanical stimulation of the feet on gait variables, clinical status, risk of falls, BDNF levels, immunological profile and brain functional connectivity changes in patients with Parkinson's disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients will be submitted to 8 sessions of peripheral mechanical stimulation of the feet or sham stimulation along 4 weeks.
Evaluations will be performed before and after the first session, after the forth and the eighth session.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazil, 90050-170
- Universidade Federal de Ciências da Saúde de Porto Alegre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of idiopathic Parkinson's disease based on clinical criteria, dopamine transporter (DaT) scans and/or magnetic resonance imaging;
- Able to walk 25 feet unassisted or with minimal assistance;
- Presenting freezing of gait;
- Aged between 50-85 years;
- Minimum score of 20 in the Mini Mental State Examination (MMSE);
Exclusion Criteria:
- Secondary musculoskeletal disorder involving the lower limb, as chondral injuries, ligament and ankle sprains which may impede the realization of the gait by pain or motion disability;
- Peripheral neuropathy;
- Not attending all the treatment;
- Absolute contraindications for fMRI (just for fMRI examination);
- Presence of deep brain stimulation;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Feet Mechanical Stimulation
The feet mechanical stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland).
Intervention: Device: Foot Mechanical Stimulation (GONDOLA)
|
Other Names:
|
Sham Comparator: Sham Feet Mechanical Stimulation
The sham stimulation will be given to all participants using GONDOLA equipment (Ecker Technologies Sagl, Switzerland).
Intervention: Device: Foot Mechanical Stimulation (GONDOLA)
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Kinetic and kinematic gait analysis
Time Frame: 4 weeks of treatment
|
Evaluated by means of the 3-D motion analysis system (BTS SMART DX 400).
|
4 weeks of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk of falls
Time Frame: 4 weeks of treatment
|
Evaluated by means of the Timed Up & Go Test (TUG).
|
4 weeks of treatment
|
Motor impairment
Time Frame: 4 weeks of treatment
|
Evaluated by means of the Unified Parkinson Disease Rating Scale (UPDRS III).
|
4 weeks of treatment
|
Level of depression
Time Frame: 4 weeks of treatment
|
Evaluated by means of the Beck Depression Inventory (BDI).
|
4 weeks of treatment
|
Symptoms of Parkinson's disease progress
Time Frame: 4 weeks of treatment
|
Evaluated by means of the Hoehn and Yahr scale.
|
4 weeks of treatment
|
Serum levels of BDNF
Time Frame: 4 weeks of treatment
|
Analyzed in blood sampling.
|
4 weeks of treatment
|
Sensorio-motor connectivity
Time Frame: 4 weeks of treatment
|
Functional magnetic resonance imaging.
|
4 weeks of treatment
|
Lymphocyte Proliferation Assessment
Time Frame: 4 weeks of treatment
|
Analyzed in blood sampling.
|
4 weeks of treatment
|
Cytokine and Cortisol Assessment
Time Frame: 4 weeks of treatment
|
Analyzed in blood sampling.
|
4 weeks of treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
September 1, 2016
Study Registration Dates
First Submitted
October 30, 2015
First Submitted That Met QC Criteria
October 30, 2015
First Posted (Estimate)
November 3, 2015
Study Record Updates
Last Update Posted (Estimate)
January 12, 2017
Last Update Submitted That Met QC Criteria
January 11, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APA2016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Neurocrine BiosciencesVoyager TherapeuticsCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia DiseaseUnited States
-
Second Affiliated Hospital of Soochow UniversityShanghai Regenelead Therapies Co., Ltd.RecruitingAdvanced Parkinson's DiseaseChina
-
AbbVieRecruitingParkinson's Disease (PD)Germany, Denmark, Spain, Israel
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Hubert FernandezRecruitingParkinson's Disease, IdiopathicUnited States
Clinical Trials on Mechanical Peripheral Stimulation (GONDOLA)
-
Universidad Católica del MauleRecruiting
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
Universidad Católica del MauleFondo Nacional de Desarrollo Científico y Tecnológico, ChileCompletedParkinson DiseaseChile
-
Istituto Clinico HumanitasCompletedInflammation | Hypertension | Parkinson's Disease | Autonomic NeuropathyItaly
-
IRCCS San Raffaele RomaTerminatedProgressive Supranuclear Palsy | Idiopathic Parkinson's DiseaseItaly
-
University of PennsylvaniaChildren's Hospital of PhiladelphiaCompletedBone AlterationUnited States
-
Hebrew SeniorLifeNational Institute on Aging (NIA)CompletedOsteopeniaUnited States
-
Balgrist University HospitalPsychiatric University Hospital, Zurich; Bern University of Applied SciencesCompleted
-
Tang-Du HospitalUnknown
-
Centre Oscar LambretTerminated